Continuing uncertainties surround anti-influenza drug
Incomplete availability of data has hampered a thorough assessment of the evidence for using the anti-influenza drug oseltamivir, a Cochrane Review has found. However, after piecing together information from over 16,000 pages ...
Jan 18, 2012
0
0